| Year |
Citation |
Score |
| 2023 |
Bayraktar A, Li X, Kim W, Zhang C, Turkez H, Shoaie S, Mardinoglu A. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients. Journal of Translational Medicine. 21: 332. PMID 37210557 DOI: 10.1186/s12967-023-04192-6 |
0.325 |
|
| 2022 |
Zhang C, Shi M, Kim W, Arif M, Klevstig M, Li X, Yang H, Bayram C, Bolat I, Tozlu ÖÖ, Hacımuftuoglu A, Yıldırım S, Sebhaoui J, Iqbal S, Wei Y, ... ... Mardinoglu A, et al. Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning. Ebiomedicine. 83: 104214. PMID 35988463 DOI: 10.1016/j.ebiom.2022.104214 |
0.301 |
|
| 2022 |
Yuan M, Shong K, Li X, Ashraf S, Shi M, Kim W, Nielsen J, Turkez H, Shoaie S, Uhlen M, Zhang C, Mardinoglu A. A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma. Cancers. 14. PMID 35326724 DOI: 10.3390/cancers14061573 |
0.312 |
|
| 2020 |
Beklen H, Gulfidan G, Arga KY, Mardinoglu A, Turanli B. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer. Frontiers in Oncology. 10: 1273. PMID 32903699 DOI: 10.3389/fonc.2020.01273 |
0.336 |
|
| 2020 |
Altay O, Mohammadi E, Lam S, Turkez H, Boren J, Nielsen J, Uhlen M, Mardinoglu A. Current Status of COVID-19 Therapies and Drug Repositioning Applications. Iscience. 23: 101303. PMID 32622261 DOI: 10.1016/j.isci.2020.101303 |
0.361 |
|
| 2019 |
Turanli B, Altay O, Borén J, Turkez H, Nielsen J, Uhlen M, Arga KY, Mardinoglu A. Systems biology based drug repositioning for development of cancer therapy. Seminars in Cancer Biology. PMID 31568815 DOI: 10.1016/J.Semcancer.2019.09.020 |
0.373 |
|
| 2019 |
Turanli B, Zhang C, Kim W, Benfeitas R, Uhlen M, Arga KY, Mardinoglu A. Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning. Ebiomedicine. PMID 30905848 DOI: 10.1016/j.ebiom.2019.03.009 |
0.319 |
|
| 2018 |
Turanli B, Grøtli M, Boren J, Nielsen J, Uhlen M, Arga KY, Mardinoglu A. Drug Repositioning for Effective Prostate Cancer Treatment. Frontiers in Physiology. 9: 500. PMID 29867548 DOI: 10.3389/fphys.2018.00500 |
0.335 |
|
| 2015 |
Mardinoglu A, Cregg PJ. Modelling the effect of SPION size in a stent assisted magnetic drug targeting system with interparticle interactions. Thescientificworldjournal. 2015: 618658. PMID 25815370 DOI: 10.1155/2015/618658 |
0.754 |
|
| 2014 |
Mardinoglu A, Uhlen M, Nielsen J. The use of Genome-scale metabolic models for drug target and biomarker identification New Biotechnology. 31: 49. DOI: 10.1016/J.Nbt.2014.05.1724 |
0.302 |
|
| 2012 |
Cregg P, Murphy K, Mardinoglu A. Inclusion of interactions in mathematical modelling of implant assisted magnetic drug targeting Applied Mathematical Modelling. 36: 1-34. DOI: 10.1016/J.APM.2011.05.036 |
0.749 |
|
| 2011 |
Mardinoglu A, Cregg PJ, Murphy K, Curtin M, Prina-Mello A. Theoretical modelling of physiologically stretched vessel in magnetisable stent assisted magnetic drug targetingapplication Journal of Magnetism and Magnetic Materials. 323: 324-329. DOI: 10.1016/j.jmmm.2010.09.028 |
0.722 |
|
| 2010 |
Cregg P, Murphy K, Mardinoglu A, Prina-Mello A. Many particle magnetic dipole–dipole and hydrodynamic interactions in magnetizable stent assisted magnetic drug targeting Journal of Magnetism and Magnetic Materials. 322: 2087-2094. DOI: 10.1016/J.JMMM.2010.01.038 |
0.755 |
|
| 2009 |
Cregg P, Murphy K, Mardinoglu A. Inclusion of magnetic dipole–dipole and hydrodynamic interactions in implant-assisted magnetic drug targeting Journal of Magnetism and Magnetic Materials. 321: 3893-3898. DOI: 10.1016/J.JMMM.2009.07.056 |
0.756 |
|
| 2008 |
Cregg P, Murphy K, Mardinoglu A. Calculation of nanoparticle capture efficiency in magnetic drug targeting Journal of Magnetism and Magnetic Materials. 320: 3272-3275. DOI: 10.1016/J.JMMM.2008.06.021 |
0.722 |
|
| Show low-probability matches. |